An update on larynx cancer

Conor Steuer(Emory University), Mark W. El‐Deiry(Emory University), Jason R. Parks(Emory University), Kristin Higgins(Emory University), Nabil F. Saba(Emory University)
CA A Cancer Journal for Clinicians
November 29, 2016
Cited by 695Open Access
Full Text

Abstract

Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common tumors of the respiratory tract. Fortunately, significant advancements have been made over the past decade in the treatment of laryngeal cancer. Although surgery has been the historical mainstay for localized disease and still is an integral part of treatment, nonsurgical options like radiation and systemic therapy have emerged as viable options. In addition, in the metastatic setting, novel agents are showing promise for this patient population. The care for patients with laryngeal cancer continues to evolve and truly requires a multidisciplinary team-based approach. Unique morbidities, such as loss of natural voice, respiration, and airway protection during swallowing, are observed with this disease and require special consideration. CA Cancer J Clin 2017;67:31-50. © 2016 American Cancer Society.


Related Papers

No related papers found

Powered by citation graph analysis